Abstract
Hypertension is a common condition worldwide that significantly increases morbidity and mortality rates in the older population. A number of treatment options are available to control blood pressure. The purpose of this study was to assess the use of health services and self-care amongst people with hypertension and to estimate the out-of-pocket expenses associated with such health care use. A sub-study of the 45 and Up Study was conducted amongst 1300 individuals who had earlier reported a clinical diagnosis of hypertension in 2017. A total of 753 (57.9%) individuals with hypertension returned a completed questionnaire. In the last 12 month, for their hypertension management, 84% of participants consulted a doctor, 19% of them consulted an allied health practitioner and 9% of them consulted a complementary medicine practitioner. The average total out-of-pocket expenditure for hypertension-related health care was Australian $461.8 per annum, with an estimated Australian $941 million per annum if extrapolated to all Australians aged 55 years and over with hypertension. Older people with hypertension use a wide range of health services to control their blood pressure including conventional medicine, allied health and complementary medicine practitioners as well as various self-care practices. A substantial amount of out-of-pocket expenditure has been spent on hypertension care annually. Given the global health and economic burden of hypertension, there is an urgent need for more research exploring cost-effective management(s) for hypertensive patients.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Egan BM, Kjeldsen SE, Grassi G, Esler M, Mancia G. The global burden of hypertension exceeds 1.4 billion people: should a systolic blood pressure target below 130 become the universal standard? J Hypertens. 2019;37:1148–53.
World Health Organization. Cardiovascular diseases (CVDs). 2017. https://www.who.int/en/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds).
Soni RK, Porter AC, Lash JP, Unruh ML. Health-related quality of life in hypertension, chronic kidney disease, and coexistent chronic health conditions. Adv Chronic Kidney Dis. 2010;17:e17–26.
Baral-Grant S, Haque M, Nouwen A, Greenfield S, McManus R. Self-monitoring of blood pressure in hypertension: a UK primary care survey. Int J Hypertens. 2011;2012:582068.
Okin PM, Hille DA, Kjeldsen SE, Dahlöf B, Devereux RB. Impact of lower achieved blood pressure on outcomes in hypertensive patients. J Hypertens. 2012;30:802–10.
Ibrahim MM, Damasceno A. Hypertension in developing countries. Lancet. 2012;380:611–9.
Merai R, Siegel C, Rakotz M, Basch P, Wright J, Wong B, et al. CDC grand rounds: a public health approach to detect and control hypertension. MMWR Morb Mortal Wkly Rep. 2016;65:1261–4.
Lo SH, Chau JP, Woo J, Thompson DR, Choi KC. Adherence to antihypertensive medication in older adults with hypertension. J Cardiovasc Nurs. 2016;31:296–303.
Rochefort CM, Morlec J, Tamblyn RM. What differentiates primary care physicians who predominantly prescribe diuretics for treating mild to moderate hypertension from those who do not? A comparative qualitative study. BMC Fam Pract. 2012;13:9.
Centers for Disease Control and Prevention. Self-management support and education. 2017. https://www.cdc.gov/dhdsp/pubs/guides/best-practices/self-management.htm.
The Ministry of Health and Medical Services, Fiji Health Sector Support Program, Australian Aid. Cardiovascular therapeutic guidelines. 2015. http://www.health.gov.fj/wp-content/uploads/2018/03/Cardiovascular-Drug-Guidelines.pdf.
Royal Australian College of General Practitioners. Guidelines for preventive activities in general practice. 2019. https://www.racgp.org.au/clinical-resources/clinical-guidelines/key-racgp-guidelines/view-all-racgp-guidelines/red-book/prevention-of-vascular-and-metabolic-disease/blood-pressure.
Penaloza-Ramos MC, Jowett S, Mant J, Schwartz C, Bray EP, Sayeed Haque M, et al. Cost-effectiveness of self-management of blood pressure in hypertensive patients over 70 years with suboptimal control and established cardiovascular disease or additional cardiovascular risk diseases (TASMIN-SR). Eur J Prev Cardiol. 2016;23:902–12.
Logan AG. Transforming hypertension management using mobile health technology for telemonitoring and self-care support. Can J Cardiol. 2013;29:579–85.
Sibbritt D, Davidson P, Peng W, Adams J, Hickman L. Hypertension: what are the self-care and health-care-seeking behaviours in women over time? J Hum Hypertens. 2016;30:783–7.
Potthoff SA, Vonend O. Multidisciplinary approach in the treatment of resistant hypertension. Curr Hypertens Rep. 2017;19:9.
Harris MF, Williams AM, Dennis SM, Zwar NA, Powell Davies G. Chronic disease self‐management: implementation with and within Australian general practice. Med J Aust. 2008;189:S17–20.
Hu H, Li G, Duan J, Arao T. Prevalence, purposes, and perceived effectiveness of complementary and alternative medicine use in a hypertension population: a questionnaire survey. Int Sch Res Not. 2013;2013:137472.
Rahmawati R, Bajorek BV. Self-medication among people living with hypertension: a review. Fam Pract. 2017;34:147–53.
45 and Up Study Collaborators, Banks E, Redman S, Jorm L, Armstrong B, Bauman A, et al. Cohort profile: the 45 and up study. Int J Epidemiol. 2008;37:941–7.
Australian Institute of Health and Welfare. Rural, regional and remote health: a guide to remoteness classifications. Canberra: Australian Institute of Health and Welfare; 2004.
Hwang W, Weller W, Ireys H, Anderson G. Out-of-pocket medical spending for care of chronic conditions. Health Aff. 2001;20:267–78.
Karter AJ, Stevens MR, Herman WH, Ettner S, Marrero DG, Safford MM, et al. Out-of-pocket costs and diabetes preventive services: the Translating Research Into Action for Diabetes (TRIAD) study. Diabetes Care. 2003;26:2294–9.
Australian Bureau of Statistics. Australian demographic statistics. 2017. https://www.ausstats.abs.gov.au/ausstats/subscriber.nsf/0/0DEC5B368C5C2D72CA2581F5001011EB/$File/31010_jun%202017.pdf.
Australian Institute of Health and WelfareCardiovascular disease. 2019. https://www.aihw.gov.au/reports/heart-stroke-vascular-disease/cardiovascular-health-compendium/contents/how-many-australians-have-cardiovascular-disease.
Lip GY, Felmeden DC, Dwivedi G. Antiplatelet agents and anticoagulants for hypertension. Cochrane Database Syst Rev. 2011;12:CD003186.
Borghi C, Dormi A, Veronesi M, Immordino V, Ambrosioni E. Use of lipid‐lowering drugs and blood pressure control in patients with arterial hypertension. J Clin Hypertens. 2002;4:277–85.
Kim KI, Ihm SH, Kim GH, Kim HC, Kim JH, Lee HY, et al. 2018 Korean society of hypertension guidelines for the management of hypertension: part III-hypertension in special situations. Clin Hypertens. 2019;25:19.
Elliott WJ. Improving outcomes in hypertensive patients: focus on adherence and persistence with antihypertensive therapy. J Clin Hypertens. 2009;11:376–82.
Guthrie B, Payne K, Alderson P, McMurdo ME, Mercer SW. Adapting clinical guidelines to take account of multimorbidity. BMJ. 2012;345:e6341.
Constant AF, Geladari EV, Geladari CV. The economic burden of hypertension. In: Andreadis EA (editors). Hypertension and cardiovascular disease. 1st ed. Springer: Switzerland; 2016. p. 351–60.
Kirkland EB, Heincelman M, Bishu KG, Schumann SO, Schreiner A, Axon RN, et al. Trends in healthcare expenditures among US adults with hypertension: national estimates, 2003–2014. J Am Heart Assoc. 2018;7:e008731.
Nakamura K, Okamura T, Miura K, Okayama A. Hypertension and medical expenditure in the Japanese population: review of prospective studies. World J Cardiol. 2014;6:531–8.
Zhang D, Wang G, Zhang P, Fang J, Ayala C. Medical expenditures associated with hypertension in the US, 2000–2013. Am J Prev Med. 2017;53:S164–71.
Acknowledgements
This research was completed by using data collected through the 45 and Up Study (www.saxinstitute.org.au). The 45 and Up Study is managed by the Sax Institute in collaboration with major partner Cancer Council NSW; and partners: the National Heart Foundation of Australia (NSW Division); NSW Ministry of Health; NSW Government Family & Community Services—Ageing, Carers and the Disability Council NSW; and the Australian Red Cross Blood Service. We thank the many thousands of people participating in the 45 and Up Study. We extend our sincere thanks to the Australian Research Council for funding Distinguished Professor JA via an ARC Professorial Future Fellowship (FT140100195) while working on this paper.
Author information
Authors and Affiliations
Contributions
DS and JA conceived this study and obtained ethical approval. DS and WP conducted data analysis. JA and MH wrote the first draft of the paper. DS and WP revised the paper. All authors approved the submitted version of the paper.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Adams, J., Hosseini, M., Peng, W. et al. Health care utilisation and out-of-pocket expenditure associated with hypertension: an analysis of Australian adults from the 45 and Up Study. J Hum Hypertens 34, 833–840 (2020). https://doi.org/10.1038/s41371-020-0363-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41371-020-0363-z